Angiography Catheters Market By Product (Scoring Balloon Catheters, Conventional Catheters, DEB Catheters, Cutting Balloon Catheters), By Application (ASCs, Hospitals, Clinics), & Region for 2024-2031

Angiography Catheters Market Valuation - 2024-2031

The angiography catheters market is experiencing a surge in demand due to several factors. Primarily, the increasing prevalence of cardiovascular diseases, such as coronary artery disease and stroke, has led to a greater need for diagnostic and interventional procedures. These catheters play a crucial role in visualizing blood vessels and performing minimally invasive treatments like angioplasty and stent placement. The market size surpass USD 1.37 Billion valued in 2024 to reach a valuation of aroundUSD 2.42 Billion by 2031.

Advancements in catheter technology, including improved materials, smaller diameters, and enhanced imaging capabilities, have made them more effective and less invasive, further driving demand. The growing aging population, which is more susceptible to cardiovascular diseases, is contributing to the market's expansion. The rising demand for cost-effective and efficient angiography catheters is enabling the market to grow at aCAGR of 7.38% from 2024 to 2031.

Angiography Catheters Market: Definition/ Overview

Angiography catheters are specialized medical devices that inject contrast media into blood arteries to make them visible on X-ray imaging during angiography operations. These catheters aid in seeing the structure and function of the heart's arteries, veins, and chambers, allowing clinicians to detect and treat a wide range of cardiovascular diseases including blockages, aneurysms, and congenital anomalies. Angiography catheters are flexible, thin tubes that are put via an artery, most commonly the femoral or radial artery, and directed to the desired region using imaging techniques.

Angiography catheters are primarily used in diagnostic and interventional cardiology to perform coronary, peripheral, and cerebral angiograms. These catheters are also used in therapeutic procedures like angioplasty, stent implantation, and embolization. With developments in imaging technology and the development of more flexible, biocompatible, and steerable catheters, the future of angiography catheters will involve more precise and least invasive procedures. The growing global prevalence of cardiovascular illnesses, combined with an increase in image-guided therapies, predicts that demand for angiography catheters will continue to climb, possibly due to developments in robotic-assisted catheterization and increased real-time imaging technology.

What's inside a VMR industry report?

Our reports include actionable data and forward-looking analysis that help you craft pitches, create business plans, build presentations and write proposals.

Will the Advancement in Technology of Catheter Design Fuel the Angiography Catheters Market?

Advancements in catheter design, notably innovations such as micro-catheters and steerable catheters, are propelling the angiography catheter market. These technical advancements enable more precise navigation in complex vascular networks, improving the accuracy and safety of angiography treatments. The FDA's approval of 43 new cardiovascular devices in 2020, many of which involve catheter technology, demonstrates the rising use of these advanced technologies.

The elderly population is likely to fuel the angiography catheter market. As the world population ages, the prevalence of cardiovascular disorders such as coronary artery disease and atherosclerosis rises, which are frequently detected and treated via angiography treatments. According to the United Nations, the number of individuals aged 65 and more is predicted to double from 703 million in 2019 to 1.5 billion by 2050. This considerable increase in the older population will fuel demand for cardiovascular tests and therapies, accelerating the expansion of the angiography catheters market.

Will the High-Cost Associated with Procedures Hamper the Growth of the Angiography Catheters Market?

The high cost of angiography operations is anticipated to have an impact on market growth for angiography catheters. These prices can limit access to such procedures, particularly in low- and middle-income countries with limited healthcare resources, lowering total demand. Hospitals and healthcare facilities may also face cost constraints when investing in sophisticated angiography equipment and catheters. Patient expenses, even in industrialized countries, may result in delayed or curtailed procedures, especially in systems with limited insurance coverage, limiting market growth.

Risks and complications can have an impact on the growth of the angiography catheter market. These catheters are utilized in crucial cardiovascular procedures, and any dangers, including infections, allergic reactions, blood vessel damage, or contrast-induced nephropathy, might cause concern among both patients and healthcare personnel. Increased awareness of these dangers may restrict market expansion as regulatory scrutiny intensifies and healthcare professionals turn to alternate diagnostic methods. Furthermore, safety concerns may influence market dynamics, pushing demand for safer solutions while potentially increasing costs, and discouraging widespread use.

Category-Wise Acumens

Will the Integration of Drug-Eluting Technology Drive the Drug-Eluting Balloon Catheters Segments for the Angiography Catheters Market?

Drug-

eluting balloon catheter segments dominate the angiography catheters market. The integration of drug-eluting technology is projected to propel the drug-eluting balloon catheters sector of the angiography catheters market. Drug-eluting balloon catheters direct therapeutic substances to the target site, lowering restenosis and enhancing patient outcomes in vascular procedures. This technology, together with increased rates of cardiovascular disease and a shift toward minimally invasive procedures, is expected to increase demand and expand the market for these advanced catheters.

The prevalence of cardiovascular illnesses is projected to drive the expansion of the drug-eluting balloon (DEB) catheter segment in the angiography catheter market. As cardiovascular disorders such as coronary artery disease and peripheral artery disease become more common, owing to aging populations and lifestyle choices, there is a greater need for better treatment alternatives. DEB catheters, which release medicines to prevent arterial re-narrowing (restenosis) during angioplasty, are a targeted and successful treatment that reduces the need for stent insertion. This makes them an appealing alternative for healthcare professionals, accelerating their adoption in response to the growing burden of cardiovascular disease.

Will the High Volume of Patients Requiring Cardiovascular Procedures Accelerate the Hospital's Segment for the Angiography Catheters Market?

Hospital's segment fastest leading in the angiography catheters market. The large volume of patients requiring cardiovascular operations is expected to boost the angiography catheters market in the hospital segment. As the prevalence of cardiovascular illnesses rises worldwide, there is an increasing demand for diagnostic and interventional techniques that rely primarily on angiography catheters. These devices are critical for diagnosing and treating coronary artery disease and peripheral vascular disease. Furthermore, advances in catheter technology and increased healthcare investments in cardiovascular care are propelling this market forward, as hospitals strive to improve diagnostic accuracy and treatment efficacy.

The availability of advanced medical equipment and qualified workers is expected to drive the hospital segment's growth in the angiography catheter market. This expansion is being driven by the rising need for precise diagnostic and therapeutic treatments that necessitate high-quality angiography catheters. Advanced equipment improves the accuracy and efficiency of these treatments, while trained clinicians make the best use of the technology, resulting in better patient results. Furthermore, the increased prevalence of cardiovascular disorders, as well as the necessity for sophisticated imaging procedures to manage these conditions, are driving up demand for advanced angiography catheters in hospitals.

Country/Region-wise Acumens

Will Improvement in Health Infrastructure in North America Boost the Angiography Catheters Market?

North America is dominating in angiography catheters market thanks to its improved health infrastructure. The growing progress of healthcare infrastructure will drive the North American angiography catheters market. North America excels in this market due to its advanced healthcare infrastructure, large patient population, and high frequency of cardiovascular disorders. With cardiovascular disease expected to affect more than 40% of the US population by 2030, the demand for sophisticated diagnostic tools such as angiography catheters will increase. Furthermore, the strong presence of major industry players and ongoing advancements will drive market expansion in the region.

The North American market for angiography catheters is predicted to rise due to an aging population. According to the United States Census Bureau, the baby boomer group will account for 73 million of the senior population by 2030. Because cardiovascular disease risk rises with age, this demographic trend is projected to boost the demand for diagnostic equipment such as angiography catheters. As a result, North America's expanding elderly population will significantly drive market demand, as more individuals will need cardiovascular evaluations and treatments.

Will Increasing Awareness of Cardiovascular Health Lead the Asia Pacific's Angiography Catheters Market?

Asia Pacific is rapidly growing in the angiography catheters market owing to its increased awareness of cardiovascular health. The increasing frequency of cardiovascular diseases (CVDs), which are the main cause of death worldwide, particularly in Asia, accounts for 35% of all deaths. As people become more conscious of their cardiovascular health, they seek diagnostic and interventional procedures, which increases the demand for angiography catheters. Furthermore, the region's aging population and expanding healthcare facilities drive up demand, positioning the market for significant development.

Government initiatives are propelling the Asia-Pacific angiography catheters market. Efforts to enhance healthcare access and affordability are driving market growth, as demonstrated in China, where coronary angiography operations increased by about 50% between 2015 and 2019, owing to rising healthcare costs and an aging population. Similarly, India's rising prevalence of cardiovascular illnesses, which is expected to exceed 103 million cases by 2030, and Japan's consistent increase in percutaneous coronary interventions (PCI) drive demand for angiography catheters, generating significant potential possibilities in the area.

Competitive Landscape

The angiography catheters market is a dynamic and competitive space, characterized by a diverse range of players vying for market share. These players are on the run for solidifying their presence through the adoption of strategic plans such as collaborations, mergers, acquisitions, and political support.

The organizations are focusing on innovating their product line to serve the vast population in diverse regions. Some of the prominent players operating in the optogenetics market include:

• Medtronic
• Boston Scientific Corporation
• Terumo Medical Corporation
• Merit Medical Systems
• AngioDynamics
• Cardinal Health
• Braun Melsungen AG
• Becton
• Dickinson and Company

Latest Developments

• In February 2022, Teleflex received Food and Drug Administration clearance for an expanded indication for specialty catheter and coronary guidewire use in crossing chronic total occlusion percutaneous coronary interventions.
• In October 2022, The HELIOSTAR Balloon Ablation Catheter is indicated for cardiac ablation and catheter-based cardiac electrophysiological mapping (stimulating and recording) of the atria beginning when combined with a suitable multi-channel RF generator.
• In July 2021, Philips announced the first minimally-invasive heart procedure using its real-time 3D intracardiac echocardiography catheter